Lung fibrosis sequelae after recovery from COVID-19 infection

Agus Dwi Susanto, Paulus Arka Triyoga, Fathiyah Isbaniah, Aulya Fairuz, Hans Cendikiawan, Ferdynand Zaron, Intan Aryanti, Sarah Naura Irbah, Moulid Hidayat

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus diseases 2019 (COVID-19). The SARS-CoV-2 is very contagious and nobody is known to be immune to it. The post-infected lung would leave a scar known as fibrosis, a scar tissue. A study from Wuhan, China suggested the development of fibrosis, though it was too early to label these lung changes as irreversible fibrosis in a time range of 3 weeks. The occurrence of fibrosis indicates a chronic infection which greatly contributes to the hallmark symptom of COVID-19 induced ARDS such as shortness of breath and chest pain. However, many of those studies have not yet explained the condition of the patient's lung after total recovery from the COVID-19. This report demonstrates the clinical symptoms, chest CT scan, spirometry, and blood gas analysis of patient after total recovery from the COVID-19 with appearance lung fibrosis.

Original languageEnglish
Pages (from-to)360-365
Number of pages6
JournalJournal of Infection in Developing Countries
Issue number3
Publication statusPublished - 31 Mar 2021


  • COVID-19
  • Lung fibrosis
  • Recovery


Dive into the research topics of 'Lung fibrosis sequelae after recovery from COVID-19 infection'. Together they form a unique fingerprint.

Cite this